The seven clinical parameters including FOB, TRF, CEA, CA19‐9, fecal F. nucleatum amount as well as gender and age were used to generate an applicable diagnostic strategy for CRC screening. This evidence concerns the gene CEACAM5 and colorectal carcinoma.